RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
110 hedge funds and large institutions have $957M invested in Revance Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 47 increasing their positions, 28 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $1.05B → $957M (-$96.8M)
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
Holders
110
Holding in Top 10
2
Calls
$2.94M
Puts
$2.19M
Top Buyers
| 1 | +$39.4M | |
| 2 | +$14.3M | |
| 3 | +$6.26M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$4.69M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.27M |
Top Sellers
| 1 | -$19.1M | |
| 2 | -$14.2M | |
| 3 | -$13.7M | |
| 4 |
Millennium Management
New York
|
-$11.3M |
| 5 |
Jennison Associates
New York
|
-$9.64M |